Beam Therapeutics's total assets for Q4 2024 were $1.10B, a decrease of -5.77% from the previous quarter. BEAM total liabilities were $370.28M for the fiscal quarter, a -2.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.